Evidence map›Paper›PMID 38629920›Full record

ArticleFuture microbiology2024

Repurposing approved drugs as potential efflux pump inhibitors in multidrug-resistant

Gláucia Morgana de Melo Guedes, Vinicius Carvalho Pereira, Alyne Soares Freitas, Paulo Roberto Honório de Souza, Aura Lucia Chacon Parra, Jaiane Alves Brasil, Rodrigo Fonseca de Medeiros Guedes, Paulo César Pereira de Sousa, Rossana de Aguiar Cordeiro, Marcos Fábio Gadelha Rocha and 2 more

Open access · greenAbstract read
In one paragraph

Article in Future microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Synergy Between the Auranofin Analogue PEtInternational journal of molecular sciences · 2026
    Article
  3. Mechanisms ofMedicina (Kaunas, Lithuania) · 2026
    Review
  4. Broadly Defined Antibiotic Adjuvants forThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026
    Review
  5. Frontiers in microbiology · 2025
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Gláucia Morgana de Melo GuedesDepartment of Pathology and Legal Medicine, Postgraduate Program in Medical Microbiology, Group of Applied Medical Microbiology, Federal University of Ceará, Fortaleza, Ceará, 60430-275, Brazil.ORCID 0000-0002-5469-8120
Vinicius Carvalho PereiraDepartment of Pathology and Legal Medicine, Postgraduate Program in Medical Microbiology, Group of Applied Medical Microbiology, Federal University of Ceará, Fortaleza, Ceará, 60430-275, Brazil.ORCID 0000-0002-5686-1630
Alyne Soares FreitasDepartment of Pathology and Legal Medicine, Postgraduate Program in Medical Microbiology, Group of Applied Medical Microbiology, Federal University of Ceará, Fortaleza, Ceará, 60430-275, Brazil.ORCID 0000-0003-3043-6094
Paulo Roberto Honório de SouzaDepartment of Pathology and Legal Medicine, Postgraduate Program in Medical Microbiology, Group of Applied Medical Microbiology, Federal University of Ceará, Fortaleza, Ceará, 60430-275, Brazil.ORCID 0000-0002-0059-7834
Aura Lucia Chacon ParraDepartment of Pathology and Legal Medicine, Postgraduate Program in Medical Microbiology, Group of Applied Medical Microbiology, Federal University of Ceará, Fortaleza, Ceará, 60430-275, Brazil.ORCID 0000-0001-6592-7374
Jaiane Alves BrasilDepartment of Pathology and Legal Medicine, Postgraduate Program in Medical Microbiology, Group of Applied Medical Microbiology, Federal University of Ceará, Fortaleza, Ceará, 60430-275, Brazil.ORCID 0000-0001-9437-1053
Rodrigo Fonseca de Medeiros GuedesDepartment of Pathology and Legal Medicine, Postgraduate Program in Medical Microbiology, Group of Applied Medical Microbiology, Federal University of Ceará, Fortaleza, Ceará, 60430-275, Brazil.ORCID 0000-0002-2856-1235
Paulo César Pereira de SousaWalter Cantídio University Hospital, Federal University of Ceará, Fortaleza, Ceará, 60430-372, Brazil.ORCID 0000-0003-1572-6886
Rossana de Aguiar CordeiroDepartment of Pathology and Legal Medicine, Postgraduate Program in Medical Microbiology, Laboratory of Emerging and Reemerging Pathogens, Federal University of Ceará, Fortaleza, Ceará, 60430-275, Brazil.ORCID 0000-0001-8386-2180
Marcos Fábio Gadelha RochaDepartment of Pathology and Legal Medicine, Postgraduate Program in Medical Microbiology, Laboratory of Emerging and Reemerging Pathogens, Federal University of Ceará, Fortaleza, Ceará, 60430-275, Brazil.ORCID 0000-0001-5482-1734
José Júlio Costa SidrimDepartment of Pathology and Legal Medicine, Postgraduate Program in Medical Microbiology, Laboratory of Emerging and Reemerging Pathogens, Federal University of Ceará, Fortaleza, Ceará, 60430-275, Brazil.ORCID 0000-0003-0086-1612
Débora de Souza Collares Maia Castelo BrancoDepartment of Pathology and Legal Medicine, Postgraduate Program in Medical Microbiology, Group of Applied Medical Microbiology, Federal University of Ceará, Fortaleza, Ceará, 60430-275, Brazil.ORCID 0000-0002-6045-2354
Universidade Federal do Ceará · BRUniversidade Estadual do Ceará · BR

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 310826/2020-9, 405312/2021-0Coordenação de Aperfeiçoamento de Pessoal de Nível SuperiorFundação Cearense de Apoio ao Desenvolvimento Científico e Tecnológico
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsBiofilmsDrug RepositioningDrug Resistance, Multiple, BacterialMicrobial Sensitivity TestsPseudomonas aeruginosaBacterial ProteinsCarbonyl Cyanide m-Chlorophenyl HydrazoneHumansHydrazonesMembrane Transport ProteinsPromethazinePseudomonas InfectionsAnti-Bacterial AgentsBacterial Proteinscarbonyl 3-chlorophenylhydrazoneCarbonyl Cyanide m-Chlorophenyl HydrazoneHydrazonesMembrane Transport ProteinsPromethazineantibiotic resistancebiofilmsefflux pumpspermeabilityPseudomonas aeruginosaRND

Identifiers

PMID38629920
PMCPMC11216505
OpenAlexW4394872872

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.